首页 > 最新文献

Journal of Gastrointestinal Surgery最新文献

英文 中文
Body mass index and survival after surgery for gastric adenocarcinoma: a population-based nationwide cohort study in Finland 体重指数与胃腺癌术后生存率——芬兰一项基于人群的全国队列研究
IF 2.4 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-11-12 DOI: 10.1016/j.gassur.2025.102282
Aapo Jalkanen , Arto Kokkola , Johanna Louhimo , Olli Helminen , Mika Helmiö , Heikki Huhta , Anna Junttila , Raija Kallio , Vesa Koivukangas , Simo Laine , Elina Lietzen , Sanna Meriläinen , Vesa-Matti Pohjanen , Tuomo Rantanen , Ari Ristimäki , Jari V. Räsänen , Juha Saarnio , Eero Sihvo , Vesa Toikkanen , Tuula Tyrväinen , Joonas H. Kauppila

Background

Gastric cancer surgery is associated with significant morbidity. Obesity is a risk factor for short-term complications. However, previous studies on the role of body mass index (BMI) as a predictor of long-term survival have conflicting results, and contemporary population-based data in the Western population are lacking. This study aimed to compare the long-term survival after gastric cancer surgery among patients who were underweight (BMI of <18.5 kg/m2), those with normal weight (BMI of 18.5–24.9 kg/m2), those who were overweight (BMI of 25.0–29.9 kg/m2), and those who were obese (BMI of >30.0 kg/m2).

Methods

This was a population-based, retrospective, nationwide cohort study in Finland using the Finnish National Esophago-Gastric Cancer Cohort. Patients who underwent gastrectomy with available height and weight data were included. A Cox regression model was used to calculate the 95% CI for 6-month to 5-year survival and 6-month survival, which was adjusted for age, sex (assigned), year of surgery, Charlson Comorbidity Index, pathological p/yp stage, neoadjuvant therapy, type of resection, and Lauren histological type.

Results

Overall, 1647 patients who underwent gastrectomy for gastric cancer were identified. Of the patients, 64 (3.9%) were underweight, 735 (44.6%) had normal weight, 584 (35.5%) were overweight, and 264 (16.0%) were obese. In the first 6 months, mortality was higher in the overweight group (hazard ratio [HR], 1.663 [95% CI, 1.158–2.389]) than in the normal weight group. However, 6-month to 5-year mortality was the highest in the underweight group (HR, 1.426 [95% CI, 1.019–1.994]) and decreased with increasing BMI (HR, 0.820 [95% CI, 0.708–0.949]). Patients with obesity had the best prognosis (HR, 0.798 [95% CI, 0.655–0.971]).

Conclusion

In this population-based study, higher BMI was associated with better long-term survival after gastric cancer surgery, somewhat offset by higher mortality during the first postoperative months, with patients with obesity having the best overall survival.
目的:比较体重过轻(体重指数(BMI) 30)胃癌患者术后的长期生存率。背景:胃癌手术与显著的发病率相关。肥胖是短期并发症的危险因素;然而,先前关于身体质量指数(BMI)作为长期生存预测指标的研究存在矛盾,当代西方人群中基于人群的数据缺乏。方法:这是一项基于人群的、回顾性的、芬兰全国队列研究,使用芬兰国家食管胃癌队列(FINEGO)。纳入有身高和体重资料的胃切除术患者。采用Cox回归模型计算6个月至5年生存率的95% CI,以及经年龄、性别、手术年份、Charlson合并症指数、病理p/yp分期、新辅助治疗、切除类型和Lauren组织学类型调整后的6个月生存率。结果:共发现1647例胃癌患者行胃切除术。体重不足64例(3.9%),正常体重735例(44.6%),超重584例(35.5%),肥胖264例(16.0%)。在前六个月,超重组的死亡率高于正常体重组(HR 1.663, 95% CI 1.158-2.389)。然而,体重不足患者的6个月至5年死亡率最高(与正常体重相比,HR为1.426,95% CI为1.019-1.994),并随着BMI的增加而降低(HR为820,95% CI为708- 0.949,与正常体重相比,超重)。肥胖患者预后最佳(HR.798 95% CI.655- 0.971)。结论:在这项基于人群的研究中,较高的BMI与胃癌手术后较好的长期生存相关,在一定程度上抵消了术后头几个月较高的死亡率,肥胖患者的总生存期最好。
{"title":"Body mass index and survival after surgery for gastric adenocarcinoma: a population-based nationwide cohort study in Finland","authors":"Aapo Jalkanen ,&nbsp;Arto Kokkola ,&nbsp;Johanna Louhimo ,&nbsp;Olli Helminen ,&nbsp;Mika Helmiö ,&nbsp;Heikki Huhta ,&nbsp;Anna Junttila ,&nbsp;Raija Kallio ,&nbsp;Vesa Koivukangas ,&nbsp;Simo Laine ,&nbsp;Elina Lietzen ,&nbsp;Sanna Meriläinen ,&nbsp;Vesa-Matti Pohjanen ,&nbsp;Tuomo Rantanen ,&nbsp;Ari Ristimäki ,&nbsp;Jari V. Räsänen ,&nbsp;Juha Saarnio ,&nbsp;Eero Sihvo ,&nbsp;Vesa Toikkanen ,&nbsp;Tuula Tyrväinen ,&nbsp;Joonas H. Kauppila","doi":"10.1016/j.gassur.2025.102282","DOIUrl":"10.1016/j.gassur.2025.102282","url":null,"abstract":"<div><h3>Background</h3><div>Gastric cancer surgery is associated with significant morbidity. Obesity is a risk factor for short-term complications. However, previous studies on the role of body mass index (BMI) as a predictor of long-term survival have conflicting results, and contemporary population-based data in the Western population are lacking. This study aimed to compare the long-term survival after gastric cancer surgery among patients who were underweight (BMI of &lt;18.5 kg/m<sup>2</sup>), those with normal weight (BMI of 18.5–24.9 kg/m<sup>2</sup>), those who were overweight (BMI of 25.0–29.9 kg/m<sup>2</sup>), and those who were obese (BMI of &gt;30.0 kg/m<sup>2</sup>).</div></div><div><h3>Methods</h3><div>This was a population-based, retrospective, nationwide cohort study in Finland using the Finnish National Esophago-Gastric Cancer Cohort. Patients who underwent gastrectomy with available height and weight data were included. A Cox regression model was used to calculate the 95% CI for 6-month to 5-year survival and 6-month survival, which was adjusted for age, sex (assigned), year of surgery, Charlson Comorbidity Index, pathological p/yp stage, neoadjuvant therapy, type of resection, and Lauren histological type.</div></div><div><h3>Results</h3><div>Overall, 1647 patients who underwent gastrectomy for gastric cancer were identified. Of the patients, 64 (3.9%) were underweight, 735 (44.6%) had normal weight, 584 (35.5%) were overweight, and 264 (16.0%) were obese. In the first 6 months, mortality was higher in the overweight group (hazard ratio [HR], 1.663 [95% CI, 1.158–2.389]) than in the normal weight group. However, 6-month to 5-year mortality was the highest in the underweight group (HR, 1.426 [95% CI, 1.019–1.994]) and decreased with increasing BMI (HR, 0.820 [95% CI, 0.708–0.949]). Patients with obesity had the best prognosis (HR, 0.798 [95% CI, 0.655–0.971]).</div></div><div><h3>Conclusion</h3><div>In this population-based study, higher BMI was associated with better long-term survival after gastric cancer surgery, somewhat offset by higher mortality during the first postoperative months, with patients with obesity having the best overall survival.</div></div>","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"30 1","pages":"Article 102282"},"PeriodicalIF":2.4,"publicationDate":"2025-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145523438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Invited commentary on “Prospective evaluation of the novel BADCAL score for predicting colorectal anastomotic leak unicorn hunt: searching for the ideal tool to predict and identify anastomotic leak” 预测结直肠吻合口瘘的新型BADCAL评分的前瞻性评价独角兽狩猎:寻找预测和识别吻合口瘘的理想工具。
IF 2.4 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-11-11 DOI: 10.1016/j.gassur.2025.102281
Frank A. DiSilvio, Terrah Paul Olson
{"title":"Invited commentary on “Prospective evaluation of the novel BADCAL score for predicting colorectal anastomotic leak unicorn hunt: searching for the ideal tool to predict and identify anastomotic leak”","authors":"Frank A. DiSilvio,&nbsp;Terrah Paul Olson","doi":"10.1016/j.gassur.2025.102281","DOIUrl":"10.1016/j.gassur.2025.102281","url":null,"abstract":"","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"30 1","pages":"Article 102281"},"PeriodicalIF":2.4,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145504909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ciliated foregut cyst of the biliary hilum mimicking choledochal cyst 胆道门纤毛前肠囊肿,酷似胆总管囊肿。
IF 2.4 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-11-07 DOI: 10.1016/j.gassur.2025.102278
Olivia Sears, Samantha M. Ruff, Victor M. Zaydfudim
{"title":"Ciliated foregut cyst of the biliary hilum mimicking choledochal cyst","authors":"Olivia Sears,&nbsp;Samantha M. Ruff,&nbsp;Victor M. Zaydfudim","doi":"10.1016/j.gassur.2025.102278","DOIUrl":"10.1016/j.gassur.2025.102278","url":null,"abstract":"","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"30 1","pages":"Article 102278"},"PeriodicalIF":2.4,"publicationDate":"2025-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145482228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conversion to permanent stoma due to poor bowel function after proctectomy with coloanal anastomosis for rectal cancer 结肠肛管吻合术治疗直肠癌直肠切除术后肠功能差致永久造口。
IF 2.4 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-11-05 DOI: 10.1016/j.gassur.2025.102277
Reena S. Suresh, Shannon N. Radomski, Miloslawa Stem, Michael Consul, Angelos Papanikolaou, Sophia Y. Chen, Susan L. Gearhart, Alodia Gabre-Kidan
{"title":"Conversion to permanent stoma due to poor bowel function after proctectomy with coloanal anastomosis for rectal cancer","authors":"Reena S. Suresh,&nbsp;Shannon N. Radomski,&nbsp;Miloslawa Stem,&nbsp;Michael Consul,&nbsp;Angelos Papanikolaou,&nbsp;Sophia Y. Chen,&nbsp;Susan L. Gearhart,&nbsp;Alodia Gabre-Kidan","doi":"10.1016/j.gassur.2025.102277","DOIUrl":"10.1016/j.gassur.2025.102277","url":null,"abstract":"","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"30 1","pages":"Article 102277"},"PeriodicalIF":2.4,"publicationDate":"2025-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145470920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glucagon-like peptide-1 receptor agonists: reshaping the surgical paradigm in obesity and gastrointestinal disease GLP-1受体激动剂:重塑肥胖和胃肠道疾病的手术模式。
IF 2.4 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-11-05 DOI: 10.1016/j.gassur.2025.102276
Vipul D. Yagnik , Prema Ram Choudhary
{"title":"Glucagon-like peptide-1 receptor agonists: reshaping the surgical paradigm in obesity and gastrointestinal disease","authors":"Vipul D. Yagnik ,&nbsp;Prema Ram Choudhary","doi":"10.1016/j.gassur.2025.102276","DOIUrl":"10.1016/j.gassur.2025.102276","url":null,"abstract":"","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"30 1","pages":"Article 102276"},"PeriodicalIF":2.4,"publicationDate":"2025-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145470934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Robotic paraganglioma resection: tactics and procedure 机器人副神经节瘤切除术:策略和程序。
IF 2.4 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-11-05 DOI: 10.1016/j.gassur.2025.102279
Fumihiro Kawano , Megan A. Lim , Claudius Conrad
{"title":"Robotic paraganglioma resection: tactics and procedure","authors":"Fumihiro Kawano ,&nbsp;Megan A. Lim ,&nbsp;Claudius Conrad","doi":"10.1016/j.gassur.2025.102279","DOIUrl":"10.1016/j.gassur.2025.102279","url":null,"abstract":"","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"30 1","pages":"Article 102279"},"PeriodicalIF":2.4,"publicationDate":"2025-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145470909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the role of preoperative serum insulin-like growth factor 1 as a predictor of survival and recurrence for patients with resectable hepatocellular carcinoma 评估术前血清胰岛素样生长因子I (IGF-I)作为可切除肝细胞癌患者生存和复发的预测因子的作用
IF 2.4 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-11-04 DOI: 10.1016/j.gassur.2025.102275
Joe Eid , Antony Haddad , Manal Hassan , Hesham M. Amin , Timothy E. Newhook , Yun Shin Chun , Ching-Wei D. Tzeng , Jean-Nicolas Vauthey , Hop S. Tran Cao , Ahmed O. Kaseb

Background

Low serum insulin-like growth factor 1 (IGF-1) level is associated with shorter overall survival (OS) in patients with advanced unresectable hepatocellular carcinoma (HCC). This study aimed to evaluate whether preoperative IGF-1 levels are associated with OS and recurrence-free survival (RFS) in patients with HCC who underwent hepatectomy.

Methods

Patients who underwent hepatectomy for HCC between 2001 and 2023 were identified from a prospectively maintained database at the MD Anderson Cancer Center. Patients with IGF-1 measured within 8 weeks after hepatectomy were included. The median IGF-1 level was used as a cutoff value to categorize high and low IGF-1 levels. The primary endpoint was OS, and the secondary endpoint was RFS.

Results

A total of 51 patients were included in this study. The median age was 66 years, and 65% of patients were males. The median IGF-1 level was 87 ng/mL. Patients with low IGF-1 levels were more likely to be ≥65 years old, with history of diabetes mellitus, hypertension, and tobacco use, and to have multinodular tumors and higher alpha-fetoprotein levels. After a median follow-up of 61 months, no difference in RFS between the high and low IGF-1 groups was found. OS was significantly longer in patients with high IGF-1 levels than in those with low IGF-1 levels (5-year OS: 80% vs 45%, respectively; P =.027). On multivariate analysis, a high IGF-1 level was significantly associated with better OS (hazard ratio, 0.33 [95% CI, 0.12–0.93]).

Conclusion

Low preoperative IGF-1 levels were a predictor of poor survival after liver resection for HCC but did not correlate with recurrence rates. This may be related to poor hepatic reserve in patients with low IGF-1 levels.
背景:低血清胰岛素样生长因子I (IGF-I)水平与晚期不可切除肝细胞癌(HCC)患者总生存期(OS)缩短相关。在这项研究中,我们试图评估术前igf - 1水平是否也可能与接受肝切除术的HCC患者的OS和无复发生存(RFS)相关。方法:从MD安德森癌症中心前瞻性维护的数据库中确定2001-2023年期间因HCC接受肝切除术的患者。纳入肝切除术后8周内测量igf - 1的患者。igf - 1的中位数水平被用作区分高和低igf - 1水平的分界线。主要终点为OS,次要终点为RFS。结果:纳入51例患者。中位年龄为66岁,65%为男性。中位igf - 1为87ng/mL。igf - 1水平低的患者年龄≥65岁,有糖尿病、高血压和吸烟史,多结节性肿瘤和AFP水平较高。中位随访61个月后,高igf - 1组和低igf - 1组的RFS没有差异。IGF-I高的患者的OS明显长于IGF-I低的患者(5年OS 80% vs 45%, p=0.027)。在多变量分析中,高IGF-I与较好的OS显著相关(HR 0.33, 95%CI 0.12-0.93)。结论:术前igf - 1水平低是HCC肝切除术后生存不良的一个预测因素,但与复发率无关。这可能与低igf - 1患者的肝储备不良有关。
{"title":"Evaluating the role of preoperative serum insulin-like growth factor 1 as a predictor of survival and recurrence for patients with resectable hepatocellular carcinoma","authors":"Joe Eid ,&nbsp;Antony Haddad ,&nbsp;Manal Hassan ,&nbsp;Hesham M. Amin ,&nbsp;Timothy E. Newhook ,&nbsp;Yun Shin Chun ,&nbsp;Ching-Wei D. Tzeng ,&nbsp;Jean-Nicolas Vauthey ,&nbsp;Hop S. Tran Cao ,&nbsp;Ahmed O. Kaseb","doi":"10.1016/j.gassur.2025.102275","DOIUrl":"10.1016/j.gassur.2025.102275","url":null,"abstract":"<div><h3>Background</h3><div>Low serum insulin-like growth factor 1 (IGF-1) level is associated with shorter overall survival (OS) in patients with advanced unresectable hepatocellular carcinoma (HCC). This study aimed to evaluate whether preoperative IGF-1 levels are associated with OS and recurrence-free survival (RFS) in patients with HCC who underwent hepatectomy.</div></div><div><h3>Methods</h3><div>Patients who underwent hepatectomy for HCC between 2001 and 2023 were identified from a prospectively maintained database at the MD Anderson Cancer Center. Patients with IGF-1 measured within 8 weeks after hepatectomy were included. The median IGF-1 level was used as a cutoff value to categorize high and low IGF-1 levels. The primary endpoint was OS, and the secondary endpoint was RFS.</div></div><div><h3>Results</h3><div>A total of 51 patients were included in this study. The median age was 66 years, and 65% of patients were males. The median IGF-1 level was 87 ng/mL. Patients with low IGF-1 levels were more likely to be ≥65 years old, with history of diabetes mellitus, hypertension, and tobacco use, and to have multinodular tumors and higher alpha-fetoprotein levels. After a median follow-up of 61 months, no difference in RFS between the high and low IGF-1 groups was found. OS was significantly longer in patients with high IGF-1 levels than in those with low IGF-1 levels (5-year OS: 80% vs 45%, respectively; <em>P</em> =.027). On multivariate analysis, a high IGF-1 level was significantly associated with better OS (hazard ratio, 0.33 [95% CI, 0.12–0.93]).</div></div><div><h3>Conclusion</h3><div>Low preoperative IGF-1 levels were a predictor of poor survival after liver resection for HCC but did not correlate with recurrence rates. This may be related to poor hepatic reserve in patients with low IGF-1 levels.</div></div>","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"30 1","pages":"Article 102275"},"PeriodicalIF":2.4,"publicationDate":"2025-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145458927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perianal angiomyofibroblastoma: rare pathology in an elderly male patient 肛门周围血管肌成纤维细胞瘤:一例老年男性患者的罕见病理。
IF 2.4 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-11-03 DOI: 10.1016/j.gassur.2025.102274
Jessica N. Figueredo, Uma R. Phatak
{"title":"Perianal angiomyofibroblastoma: rare pathology in an elderly male patient","authors":"Jessica N. Figueredo,&nbsp;Uma R. Phatak","doi":"10.1016/j.gassur.2025.102274","DOIUrl":"10.1016/j.gassur.2025.102274","url":null,"abstract":"","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"30 1","pages":"Article 102274"},"PeriodicalIF":2.4,"publicationDate":"2025-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145452136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Time-space analysis of gastrointestinal cancers among the working-age individuals in Brazil, Russia, India, China, and South Africa (BRICS)-plus countries (1990–2021): a comprehensive analysis from the Global Burden of Disease Study 2021 金砖四国+国家工作年龄人群胃肠癌的时空分析(1990-2021年):来自2021年全球疾病负担研究的综合分析
IF 2.4 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-10-30 DOI: 10.1016/j.gassur.2025.102271
Minxia Yang , Liejiong Wang , Zhaoqi Qiu , Ying Lou , Feng Xuan

Background

Gastrointestinal (GI) cancers remain a major public health concern worldwide. However, limited evidence exists on the burden and trends of these cancers among the economically active population in BRICS-plus countries, including Brazil, Russia, India, China, South Africa, Egypt, Ethiopia, Iran, Saudi Arabia, and the United Arab Emirates. This study aimed to assess the long-term patterns and current status of 6 major GI cancers among working-age adults (20–64 years) across these countries between 1990 and 2021.

Methods

This study used data from the Global Burden of Disease Study 2021 to analyze disability-adjusted life years (DALYs) related to 6 GI cancers: colorectal, esophageal, stomach, liver, gallbladder and biliary tract, and pancreatic cancers. Trends in age-standardized DALY rates (ASDRs) were evaluated over time, and changes in DALYs were further examined using decomposition analysis to identify contributions from population growth, aging, and changes in disease prevalence and severity.

Results

In 2021, China had the highest ASDRs of GI cancers among BRICS-plus countries, contributing more than 17 million DALYs. Of note, 4 cancers (colorectal, esophageal, stomach, and liver) together accounted for more than 70% of the total GI cancer burden between 1990 and 2021. Although the overall number of DALYs increased in most countries, largely due to population growth, the ASDRs decreased in most BRICS-plus countries, except Egypt. Reductions were most pronounced in patients with esophageal and stomach cancers. Men had a higher burden for most GI cancers than women, except for gallbladder and biliary tract cancers, in which women were more affected. The highest burden was observed in individuals aged 60 to 64 years.

Conclusion

GI cancers place a substantial and growing burden on the working-age population in BRICS-plus countries. Substantial disparities in cancer burden were observed across time, age, sex, and country, highlighting the urgent need for tailored public health strategies.
背景:胃肠道癌症仍然是世界范围内主要的公共卫生问题。本研究旨在评估1990年至2021年间这些国家工作年龄成年人(20-64岁)中六种主要胃肠道癌症的长期模式和现状。方法:我们使用2021年全球疾病负担研究的数据来分析与六种胃肠道癌症相关的残疾调整生命年(DALYs):结直肠癌、食管癌、胃癌、肝癌、胆囊和胆道癌以及胰腺癌。随着时间的推移,对年龄标准化DALY率的趋势进行了评估,并使用分解分析进一步检查DALY的变化,以确定人口增长、老龄化以及疾病患病率和严重程度的变化对DALY的贡献。结果:2021年,中国胃肠道癌症年龄标准化DALY率在金砖四国中最高,贡献了超过1700万DALY。1990年和2021年,四种癌症(结直肠癌、食管癌、胃癌和肝癌)合计占胃肠道癌症总负担的70%以上。虽然大多数国家的DALY总数增加,主要是由于人口增长,但除埃及外,大多数金砖四国+国家的年龄标准化DALY率下降。食道癌和胃癌的减少最为明显。与女性相比,男性患大多数胃肠道癌症的负担更高,但胆囊和胆道癌症除外,女性在这两种癌症中更容易受到影响。60-64岁人群的负担最高。结论:胃肠道癌症给金砖四国及以上国家的劳动年龄人口带来了巨大且日益增长的负担。观察到癌症负担在不同时间、年龄、性别和国家之间存在巨大差异,突出表明迫切需要制定有针对性的公共卫生战略。
{"title":"Time-space analysis of gastrointestinal cancers among the working-age individuals in Brazil, Russia, India, China, and South Africa (BRICS)-plus countries (1990–2021): a comprehensive analysis from the Global Burden of Disease Study 2021","authors":"Minxia Yang ,&nbsp;Liejiong Wang ,&nbsp;Zhaoqi Qiu ,&nbsp;Ying Lou ,&nbsp;Feng Xuan","doi":"10.1016/j.gassur.2025.102271","DOIUrl":"10.1016/j.gassur.2025.102271","url":null,"abstract":"<div><h3>Background</h3><div>Gastrointestinal (GI) cancers remain a major public health concern worldwide. However, limited evidence exists on the burden and trends of these cancers among the economically active population in BRICS-plus countries, including Brazil, Russia, India, China, South Africa, Egypt, Ethiopia, Iran, Saudi Arabia, and the United Arab Emirates. This study aimed to assess the long-term patterns and current status of 6 major GI cancers among working-age adults (20–64 years) across these countries between 1990 and 2021.</div></div><div><h3>Methods</h3><div>This study used data from the Global Burden of Disease Study 2021 to analyze disability-adjusted life years (DALYs) related to 6 GI cancers: colorectal, esophageal, stomach, liver, gallbladder and biliary tract, and pancreatic cancers. Trends in age-standardized DALY rates (ASDRs) were evaluated over time, and changes in DALYs were further examined using decomposition analysis to identify contributions from population growth, aging, and changes in disease prevalence and severity.</div></div><div><h3>Results</h3><div>In 2021, China had the highest ASDRs of GI cancers among BRICS-plus countries, contributing more than 17 million DALYs. Of note, 4 cancers (colorectal, esophageal, stomach, and liver) together accounted for more than 70% of the total GI cancer burden between 1990 and 2021. Although the overall number of DALYs increased in most countries, largely due to population growth, the ASDRs decreased in most BRICS-plus countries, except Egypt. Reductions were most pronounced in patients with esophageal and stomach cancers. Men had a higher burden for most GI cancers than women, except for gallbladder and biliary tract cancers, in which women were more affected. The highest burden was observed in individuals aged 60 to 64 years.</div></div><div><h3>Conclusion</h3><div>GI cancers place a substantial and growing burden on the working-age population in BRICS-plus countries. Substantial disparities in cancer burden were observed across time, age, sex, and country, highlighting the urgent need for tailored public health strategies.</div></div>","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"30 1","pages":"Article 102271"},"PeriodicalIF":2.4,"publicationDate":"2025-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145421917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of same-day discharge after robotic hiatal hernia repair: a comparative study 机器人裂孔疝修补术后当日出院的结果:一项比较研究。
IF 2.4 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-10-30 DOI: 10.1016/j.gassur.2025.102270
Niloufar Salehi, Sophia Luo, Teagan Marshall, Hala Al Asadi, Anjani Turaga, Maria Alqamish, Sayani Saha, Jacques Greenberg, Brendan M. Finnerty, Thomas J. Fahey III, Rasa Zarnegar
<div><h3>Background</h3><div>With the increasing use of minimally invasive techniques and recovery protocols, hiatal hernia repair is increasingly performed with a same-day discharge (SDD) approach. This study aimed to identify factors affecting patient selection for SDD at a tertiary center and compare the outcomes of SDD with extended observation stay (EOS) after robotic hiatal hernia repair.</div></div><div><h3>Methods</h3><div>This was a retrospective review of patients who underwent robotic hiatal hernia repair from January 2012 to April 2024. Patients who had SDD were those managed in ambulatory care and discharged within 12 h of admission. This study compared perioperative characteristics and postoperative outcomes, including emergency department (ED) returns and readmissions. Multivariate logistic regression identified risk factors for ED returns and 30-day readmission.</div></div><div><h3>Results</h3><div>Among 740 included patients, 464 had EOS, and 276 had SDD. There was a growing trend toward SDD. Patients who had EOS were generally older (<em>P</em> <.001); had higher comorbidity rates (diabetes mellitus [<em>P</em> =.006], hypertension [<em>P</em> =.034], and pulmonary disease [<em>P</em> =.013]); had more paraesophageal hernias (<em>P</em> =.002); and presented with more severe dysphagia (<em>P</em> =.019) and elevated American Society of Anesthesiologists (ASA) scores (<em>P</em> <.001). In addition, patients who had EOS underwent more revisional surgical procedures (<em>P</em> <.001), Collis procedures (<em>P</em> <.001), relaxing incisions (<em>P</em> <.001), and Nissen fundoplications (<em>P</em> =.028), whereas patients who had SDD more frequently received magnetic sphincter augmentation (MSA; <em>P</em> =.007). Most patients who had EOS had longer operative duration (<em>P</em> =.001) and were evening/night cases (<em>P</em> =.002), with an average hospital stay of 26.8 h (IQR, 20.8–32.0) compared with 9.0 h (IQR, 8.0–10.0) for patients who had SDD (<em>P</em> <.001). However, postoperative outcomes, including ED returns, readmissions, gastroesophageal reflux disease symptoms, and dysphagia, were comparable. Multivariate analysis revealed that a higher ASA score (odds ratio [OR], 1.8 [95% CI, 1.1–3.0]; <em>P</em> =.037) and paraesophageal hernia (OR, 2.2 [95% CI, 1.2–4.1]; <em>P</em> =.011) were associated with a higher ED returns and that MSA was associated with a lower ED return rate than Toupet fundoplication (OR, 0.2 [95% CI, 0.1–0.9]; <em>P</em> =.021). Diabetes mellitus (OR, 3.1 [95% CI, 1.5–6.0]; <em>P</em> =.002) and paraesophageal hernia (OR, 2.2 [95% CI, 1.2–4.4]; <em>P</em> =.016) increased the odds of 30-day readmission.</div></div><div><h3>Conclusion</h3><div>SDD after robotic hiatal hernia repair is safe and feasible, with outcomes similar to those of EOS when patients are appropriately selected. Higher ASA score, diabetes mellitus, paraesophageal hernia, and Toupet fundoplication are associate
背景:随着微创技术和康复方案的使用越来越多,裂孔疝修补越来越多地采用当日出院(SDD)方法进行。本研究旨在确定影响三级中心患者选择SDD的因素,并比较机器人裂孔疝修补术后SDD与延长观察时间(EOS)的结果。方法:回顾性分析2012年1月至2024年4月接受机器人裂孔疝修补术的患者。SDD患者是那些在门诊治疗并在入院12小时内出院的患者。我们比较了围手术期特征和术后结果,包括急诊室(ER)返回和再入院。多因素logistic回归确定了ER复发和30天再入院的危险因素。结果:740例患者中,EOS患者464例,SDD患者276例。SDD的发展趋势越来越明显。结论:机器人裂孔疝修补术后的SDD是安全可行的,当患者选择适当时,其结果与EOS相似。与磁力括约肌增强术相比,较高的ASA评分、糖尿病、食管旁疝和Toupet底重叠与ER返回和再入院率增加有关,这突出了个性化患者选择的必要性。优化围手术期及术后护理可进一步改善裂孔疝修补术后SDD。
{"title":"Outcomes of same-day discharge after robotic hiatal hernia repair: a comparative study","authors":"Niloufar Salehi,&nbsp;Sophia Luo,&nbsp;Teagan Marshall,&nbsp;Hala Al Asadi,&nbsp;Anjani Turaga,&nbsp;Maria Alqamish,&nbsp;Sayani Saha,&nbsp;Jacques Greenberg,&nbsp;Brendan M. Finnerty,&nbsp;Thomas J. Fahey III,&nbsp;Rasa Zarnegar","doi":"10.1016/j.gassur.2025.102270","DOIUrl":"10.1016/j.gassur.2025.102270","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;div&gt;With the increasing use of minimally invasive techniques and recovery protocols, hiatal hernia repair is increasingly performed with a same-day discharge (SDD) approach. This study aimed to identify factors affecting patient selection for SDD at a tertiary center and compare the outcomes of SDD with extended observation stay (EOS) after robotic hiatal hernia repair.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;This was a retrospective review of patients who underwent robotic hiatal hernia repair from January 2012 to April 2024. Patients who had SDD were those managed in ambulatory care and discharged within 12 h of admission. This study compared perioperative characteristics and postoperative outcomes, including emergency department (ED) returns and readmissions. Multivariate logistic regression identified risk factors for ED returns and 30-day readmission.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;Among 740 included patients, 464 had EOS, and 276 had SDD. There was a growing trend toward SDD. Patients who had EOS were generally older (&lt;em&gt;P&lt;/em&gt; &lt;.001); had higher comorbidity rates (diabetes mellitus [&lt;em&gt;P&lt;/em&gt; =.006], hypertension [&lt;em&gt;P&lt;/em&gt; =.034], and pulmonary disease [&lt;em&gt;P&lt;/em&gt; =.013]); had more paraesophageal hernias (&lt;em&gt;P&lt;/em&gt; =.002); and presented with more severe dysphagia (&lt;em&gt;P&lt;/em&gt; =.019) and elevated American Society of Anesthesiologists (ASA) scores (&lt;em&gt;P&lt;/em&gt; &lt;.001). In addition, patients who had EOS underwent more revisional surgical procedures (&lt;em&gt;P&lt;/em&gt; &lt;.001), Collis procedures (&lt;em&gt;P&lt;/em&gt; &lt;.001), relaxing incisions (&lt;em&gt;P&lt;/em&gt; &lt;.001), and Nissen fundoplications (&lt;em&gt;P&lt;/em&gt; =.028), whereas patients who had SDD more frequently received magnetic sphincter augmentation (MSA; &lt;em&gt;P&lt;/em&gt; =.007). Most patients who had EOS had longer operative duration (&lt;em&gt;P&lt;/em&gt; =.001) and were evening/night cases (&lt;em&gt;P&lt;/em&gt; =.002), with an average hospital stay of 26.8 h (IQR, 20.8–32.0) compared with 9.0 h (IQR, 8.0–10.0) for patients who had SDD (&lt;em&gt;P&lt;/em&gt; &lt;.001). However, postoperative outcomes, including ED returns, readmissions, gastroesophageal reflux disease symptoms, and dysphagia, were comparable. Multivariate analysis revealed that a higher ASA score (odds ratio [OR], 1.8 [95% CI, 1.1–3.0]; &lt;em&gt;P&lt;/em&gt; =.037) and paraesophageal hernia (OR, 2.2 [95% CI, 1.2–4.1]; &lt;em&gt;P&lt;/em&gt; =.011) were associated with a higher ED returns and that MSA was associated with a lower ED return rate than Toupet fundoplication (OR, 0.2 [95% CI, 0.1–0.9]; &lt;em&gt;P&lt;/em&gt; =.021). Diabetes mellitus (OR, 3.1 [95% CI, 1.5–6.0]; &lt;em&gt;P&lt;/em&gt; =.002) and paraesophageal hernia (OR, 2.2 [95% CI, 1.2–4.4]; &lt;em&gt;P&lt;/em&gt; =.016) increased the odds of 30-day readmission.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;SDD after robotic hiatal hernia repair is safe and feasible, with outcomes similar to those of EOS when patients are appropriately selected. Higher ASA score, diabetes mellitus, paraesophageal hernia, and Toupet fundoplication are associate","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"30 1","pages":"Article 102270"},"PeriodicalIF":2.4,"publicationDate":"2025-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145426786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Gastrointestinal Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1